Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials

Figures

• 

  Fig. 1. Flow diagram of study selection

• 

  Fig. 2. Methodological quality of the included studies

• 

  Fig. 3. Forest plots of albuminuria after statins or placebo therapy in patients with albuminuria <30 mg/day, 30 to 300 mg/day, and >300 mg/day

• 

  Fig. 4. Forest plots of albuminuria after statins or placebo therapy in nephropathy patients with T1DM or T2DM

• 

  Fig. 5. Forest plots of UAER (ug/min) for statins versus placebo in patients with diabetic nephropathy

• 

  Fig. 6. Funnel plot of publication bias for the effects of statins on renal outcomes in diabetic nephropathy

• 

  Fig. 7. Sensitivity analysis for the efficacy of statins on UAER in patients with diabetic nephropathy